Recharge Capital announced a $200M fund that aims to invest in women's health and fertility care startups across Southeast Asia, Latin America, Europe, and the Middle East. In addition to funding, the New York-based VC firm will also incubate startups. The fund has received backing from Peter Thiel, the Disney family's Shamrock Holdings, Blue Lion Group, and others. - Notable startups in its portfolio include fertility services clinic Generation Prime, IVF software firm Embryonics, and menstrual wellness startup Elix Healing.
- Recharge's women's healthcare investment fund will use a milestone-based deployment model instead of a capital call model.
- Milestones will be linked to revenue and EBITDA.
- A milestone-driven deployment schedule gives investors greater visibility into how capital is allocated, per Recharge Capital's founding partner Lorin Gu.
|
